August 2012 Briefing - HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for August 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Once-Daily Pill Approved to Treat HIV
TUESDAY, Aug. 28 (HealthDay News) -- Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) has been approved by the U.S. Food and Drug Administration to treat adults with HIV.
AAP: Health Benefits of Male Circumcision Outweigh Risks
MONDAY, Aug. 27 (HealthDay News) -- The health benefits of circumcision for newborn males outweigh the risks, according to a policy statement from the American Academy of Pediatrics (AAP) published online Aug. 27 in Pediatrics.
Fewer Circumcisions May Increase Infections and Costs
WEDNESDAY, Aug. 22 (HealthDay News) -- The reduced rate of neonatal male circumcision (MC) procedures performed in the United States is estimated to lead to increased infection prevalence and higher medical costs for men and women, according to a study published online Aug. 20 in the Archives of Pediatrics & Adolescent Medicine.
Prevalence of TB, Hepatitis C, HIV High Among Homeless
MONDAY, Aug. 20 (HealthDay News) -- The global prevalence of tuberculosis, hepatitis C virus infection, and HIV is high among homeless people, although significant heterogeneity is seen in prevalence estimates, according to a study published online Aug. 20 in The Lancet Infectious Diseases.
Substance in Human Breast Milk Protects Against HIV Transmission
MONDAY, Aug. 20 (HealthDay News) -- High concentrations of specific human milk oligosaccharides (HMO) appear to be protective against postnatal HIV transmission, according to research published online Aug. 15 in the American Journal of Clinical Nutrition.
Clinicians Can Unintentionally Prompt Nocebo Effect
THURSDAY, Aug. 2 (HealthDay News) -- The nocebo effect, or induction of a symptom perceived as negative by sham treatment and/or the suggestion of negative expectation, may arise from suggestions by doctors and nurses, according to a study published in Deutsches Ärzteblatt International.
Cellular Mechanisms of HIV-1 Dissemination Elucidated
THURSDAY, Aug. 2 (HealthDay News) -- HIV-1-infected T cells are motile, form syncytia, and play a key role in HIV dissemination, according to a letter to the editor published online Aug. 1 in Nature.